Pharmaceutical Water Market Size, Share, Growth, Trends, Scope, Report 2021-2030
According to latest report, the global pharmaceutical water market reached value at US$ 24.5 Bn in 2020 and projected to hit US$ 72 billion by 2030, expanding growth at a CAGR of 10.1% from 2021 to 2030. The growth of biopharmaceutical and generic injectable drugs industries is projected to drive the global pharmaceutical water market in the near future.
HPLC grade water is essential for preparing mobile phases and samples. Water used in the HPLC process should be purified through a combination of distillation, reverse osmosis, ultraviolet irradiation, filtering, ion exchange, and other methods. Water for HPLC should comply with the highest purity specified under type 1 by the American Society for Testing and Materials (ASTM). This water requires mixed bed deionization and filtration with 0.2μ membrane filters. Water for injection, or sterile water for injection, is a non-pyrogenic, sterile, solute-free preparation. It is utilized as sterile solvent or diluent vehicle for solutions or drugs suitable for parenteral administration. It is also used in cell culture as a solvent in the preparation of cell culture media, buffers, laboratory reagents, reconstitution of biochemical reagents, and final rinse water for critical applications and bioprocess liquids.
Demand for biopharmaceuticals such as vaccines, proteins, antibodies, plasma, enzymes, biologics, and peptides is high for use in the production of life-saving medications. These biologicals are unstable in solution if stored over a long period of time.
The biopharmaceutical sector has expanded rapidly in the past few years. It is expected to grow at a rapid pace in the near future. Currently, the biopharmaceutical sector is valued at US$ 163 Bn. It is likely to expand at a CAGR of 8% over the next few years, nearly double that of the conventional pharmaceutical sector.
Growth of the biopharmaceutical industry can be attributed to large unmet medical needs in the treatment of chronic medical conditions, patent expiry of branded biologic drugs leading to development of biosimilar drugs, and a large number of clinical pipeline drugs. Moreover, rapid expansion of the vaccines industry is projected to propel the biopharmaceutical industry in the near future.
Players operating in the generic injectable market are focused on the development of generic injectable products, especially generic biologic products i.e., biosimilars.
Presently, 28 biosimilar drugs have been approved by the U.S. FDA for the treatment of different types of chronic medical conditions.
Increase in focus of leading players on the development and expansion of manufacturing facilities suitable for generic formulations is anticipated to boost the production of specialty generic injectable products during the forecast period.
Development of generic formulations is a more rapid process compared to branded ones, as these products are exempt from the requirement to conduct clinical trials and toxicity studies. Large number of players are entering the global generic injectable market with cost-effective alternatives to branded products, leading to increased adoption of generic products.
Pharmaceutical water is an integral part of the biopharmaceutical and generic injectable industries. Hence, demand for pharmaceutical water is expected to increase, along with the expansion of the biopharmaceutical and generic injectable industries during the forecast period.
Rapid increase in burden of diabetes among the geriatric and obese population across the globe is a major factor likely to propel the global pharmaceutical water market during the forecast period.
According to Diabetes Research and Clinical Practice, the global prevalence of diabetes was around 9.3% (463 million people) in 2019. The rate of prevalence is projected to increase to 10.2% (578 million) in 2030 and 10.9% (700 million) by 2045.
Globally, around 46% people with diabetes are still undiagnosed, which provides significant opportunity in the pharmaceutical water market.
In the global diabetes care industry, the injectable drugs segment is anticipated to expand at a CAGR of 17.8%, compared to 15.1% of the total industry, and 11% of the oral anti-diabetics segment between 2009 and 2019.
Report Highlights
In terms of end user, the global pharmaceutical water market has been classified into pharmaceutical & biotechnology companies, academics & research laboratories, and others. The pharmaceutical & biotechnology companies segment held a significant share of the global pharmaceutical water market in 2020.
North America held major share of the global pharmaceutical water market in 2020. Presence of key players and growth strategies adopted by these players are the major factors driving the pharmaceutical water market in the region. Rise in awareness about the benefits of prevention of diseases and increase in healthcare expenditure also augment the pharmaceutical water market in North America.
Asia Pacific was the second largest market for pharmaceutical water in 2020. The growth of the pharmaceutical water market in Asia Pacific can be attributed to rise in infectious diseases and a well-developed healthcare sector. The pharmaceutical water market in Asia Pacific is likely to grow at a rapid pace during the forecast period. Development of pharmaceutical water and other pharma products to cope with diseases and rise in awareness leading to routine checkup and diagnosis are the major factors anticipated to drive the pharmaceutical water market in Asia Pacific.
Key Players
Key players are expanding their footprint to consolidate their positions in the global pharmaceutical water market. Greater emphasis on prevention and wellness by healthcare professionals and owners presents lucrative opportunities to key players to increase their share in the global pharmaceutical water market. Hence, manufacturers engage in new product development, collaborations, and distribution to gain market share.
Leading players operating in the global pharmaceutical water market include Merck KGaA, B. Braun Melsungen AG, Baxter International, Inc., Thermo Fisher Scientific, Inc., Cytiva (Danaher), Intermountain Life Sciences, Standard Reagents, Pvt. Ltd., CovaChem, LLC., FUJIFILM Irvine Scientific, Fresenius Kabi AG, and Pfizer, Inc.
Market Segmentation
By Type
By End User
Pharmaceutical Water Market, by Region
This report focuses on pharmaceutical water market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall pharmaceutical water market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global pharmaceutical water market.
The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.
In order to understand and assess opportunities in this market, the report is categorically divided into five key sections on the basis of segments. The report analyzes the global market in terms of value (US$ dollers) and volume (Million Units).
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Regional Analysis
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global pharmaceutical water market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the pharmaceutical water market.
The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.
In this study, the years considered to estimate the market size of pharmaceutical water are as follows:
Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2017 to 2019.
The analysts have provided a comprehensive analysis of the competitive landscape of the global pharmaceutical water market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation expected to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users) and other segments.
Research Methodology
The research methodology adopted by analysts for compiling the global pharmaceutical water market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global pharmaceutical water market.
The study objectives of this report are:
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers